Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Visit Blog


Nick Waddell

Nick is President of Cantech Media and Founding Editor of Cantech Letter. Nick has fifteen years experience with public technology companies in the areas of corporate communications and corporate finance. Nick is also a contributor to publications such as Canadian Business and Business Insider. Prior to this work, Nick was a writer and editor with Monday Publications in Victoria, BC and, in the early 1990’s was a VP with one of the world’s first profitable internet sites, Canadian Stock Market Reporter. Nick majored in English and minored in Economics at The University of Guelph and Simon Fraser University.

Latest Articles

Columbia Care is hugely undervalued, Beacon Securities says

Beacon Securities analyst Russell Stanley likes the look of US cannabis play Columbia Care (Columbia Care Stock Quote, Chart, News NEO:CCHW), which just opened four more dispensaries —one in Maryland, one in Delaware and two more in Florida. In an...

Medicenna Therapeutics has an upside of 187 per cent, Mackie says

After recent news from clinical-stage biotech company Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News TSX:MDNA), Mackie Research Capital Corporation analyst André Uddin made some adjustments to his model. But in a client upd...

Buy Medtronic for the long term, this investor says

Large-cap medical technology company Medtronic (Medtronic Stock Quote, Chart, News NYSE:MDT) has had a heck of a year, with the stock racing upwards in response to consistent quarterly beats. But even with all those gains there’s likely still upsi...

Jim Cramer sounds off on Canopy Growth Corp

What does Canopy Growth Corp need? Jim Cramer will tell you. The headlines haven’t exactly been friendly over the past few months to cannabis company Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED), what with the ousting ...

Microsoft stock is getting expensive, this fund manager says

Microsoft (Microsoft Stock Quote, Chart, News NASDAQ:MSFT) has been hanging around its all-time high for a few months now, but is there upside left to the name? Maybe, says Empire Life’s Ashley Misquitta, who claims that it’s unclear whether or ...